Through study of the role of the pioneering transcription factor KLF4 in CML pathogenesis, the kinase DYRK2 was identified as a novel master regulator of a CML network involved in the self-renewal and survival of LSCs14. This evidence concerns the gene DYRK2 and chronic myelogenous leukemia, BCR-ABL1 positive.